Robert M. Anglin, VP Quality & Regulatory at ROCHESTER MEDICAL CORPORATION (ROCM), sold 4,000 shares at $14.70 ($59K) on 2013-03-01, disclosed to the SEC on 2013-03-04.
Open-market sale of $59k ROCM by VP Quality & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.